Cellcarta

Cellcarta company information, Employees & Contact Information

Explore related pages

Related company profiles:

As a global leader in precision medicine testing services, we partner with our clients to address the most complex biomarker and bioanalytical challenges and deliver highly customized testing solutions. With facilities located in Canada, United States, Belgium, Australia and China, CellCarta provides the expertise needed locally to support global clinical trials. CellCarta offers access to integrated analytical platforms in immunology (immune monitoring), histopathology, proteomics and genomics, as well as digital pathology/AI and sample management, logistics and kitting services. At CellCarta we are experts at assessing the immune system, whether in the context of oncology, infectious diseases, or autoimmune diseases. With a proven track record in other therapeutic areas as, such as neurological and metabolic disorders, we handle all human biological specimens and deploy relevant technologies to extract valuable information for research and diagnostic applications. We provide assay development and testing services to support a wide variety of translational research, clinical trials, and diagnostic applications. Reflecting our commitment to quality, our sites hold the appropriate accreditations to support your regulatory requirements, including CAP, CLIA, ISO15189, ISO27001 and ISO13485.
Looking for a particular Cellcarta employee's phone or email?

Cellcarta Questions

News

Lunit, CellCarta Announce Global Alliance to Expand Access to Digital Pathology AI for Clinical Trials - PR Newswire

Lunit, CellCarta Announce Global Alliance to Expand Access to Digital Pathology AI for Clinical Trials PR Newswire

Lunit and CellCarta to integrate AI pathology in clinical trials - Medical Device Network

Lunit and CellCarta to integrate AI pathology in clinical trials Medical Device Network

Company profile: CellCarta - ic.gc.ca

Company profile: CellCarta ic.gc.ca

Biofidelity and CellCarta partner to deploy Aspyre Lung in global clinical trials - PharmaTimes

Biofidelity and CellCarta partner to deploy Aspyre Lung in global clinical trials PharmaTimes

Biofidelity and CellCarta partner to deploy Aspyre® Lung in global clinical trials - PR Newswire

Biofidelity and CellCarta partner to deploy Aspyre® Lung in global clinical trials PR Newswire

Achieving Reliable Cross-Laboratory Flow Cytometry Instrument Standardization - Genetic Engineering and Biotechnology News

Achieving Reliable Cross-Laboratory Flow Cytometry Instrument Standardization Genetic Engineering and Biotechnology News

Arsenal-backed CellCarta expands portfolio with new purchase - pehub.com

Arsenal-backed CellCarta expands portfolio with new purchase pehub.com

Clario partners with CellCarta to streamline trial tissue, sample handling - Fierce Biotech

Clario partners with CellCarta to streamline trial tissue, sample handling Fierce Biotech

CERo Therapeutics Holdings, Inc. Announces Progress in Initiation of Phase 1 Clinical Trial by Executing an Agreement with Contract Research Organization CellCarta to Manage Translational Assays - GlobeNewswire

CERo Therapeutics Holdings, Inc. Announces Progress in Initiation of Phase 1 Clinical Trial by Executing an Agreement with Contract Research Organization CellCarta to Manage Translational Assays GlobeNewswire

Precision Medicine Leader Caprion-HistoGeneX Rebrands as CellCarta - PR Newswire Canada

Precision Medicine Leader Caprion-HistoGeneX Rebrands as CellCarta PR Newswire Canada

CellCarta Holds Ribbon Cutting For New Expanded Space in Naperville - NCTV17

CellCarta Holds Ribbon Cutting For New Expanded Space in Naperville NCTV17

Lunit partners with CellCarta to expand global clinical trial use of AI biomarker platform - koreabiomed.com

Lunit partners with CellCarta to expand global clinical trial use of AI biomarker platform koreabiomed.com

Caprion-HistoGeneX Rebrands as CellCarta - Contract Pharma

Caprion-HistoGeneX Rebrands as CellCarta Contract Pharma

CellCarta Strengthens its Histological Biomarker Franchise by Acquiring Artificial Intelligence-Based Quantitative Pathology Leader Reveal Biosciences - BioSpace

CellCarta Strengthens its Histological Biomarker Franchise by Acquiring Artificial Intelligence-Based Quantitative Pathology Leader Reveal Biosciences BioSpace

Jadco, CellCarta partner on Montreal life sciences hub - constructconnect.com

Jadco, CellCarta partner on Montreal life sciences hub constructconnect.com

CellCarta acquires Biogazelle to strengthen its genomic capabilities and expand into digital PCR (dPCR) services - PR Newswire

CellCarta acquires Biogazelle to strengthen its genomic capabilities and expand into digital PCR (dPCR) services PR Newswire

Top Cellcarta Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant